xanthenes has been researched along with sirolimus in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MacMillan, D; McCarron, JG | 1 |
| Barger, JF; Gallo, CA; Merk, L; Nelson, S; Plas, DR; Seibel, WL; Torni, KA | 1 |
| Chaki, S; Iijima, M; Koike, H | 1 |
| Anwyl, R; Chang, L; Chen, X; Lin, R; Wang, C; Wang, Q; Wei, X; Xu, S; Zhang, J | 1 |
| Al Mamun Bhuyan, A; Cao, H; Lang, F | 1 |
5 other study(ies) available for xanthenes and sirolimus
| Article | Year |
|---|---|
Regulation by FK506 and rapamycin of Ca2+ release from the sarcoplasmic reticulum in vascular smooth muscle: the role of FK506 binding proteins and mTOR.
Topics: Aniline Compounds; Animals; Calcium; Electrophysiology; Fluorescent Dyes; Guinea Pigs; Immunosuppressive Agents; Male; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Portal Vein; Sarcoplasmic Reticulum; Sirolimus; Tacrolimus; Tacrolimus Binding Proteins; Xanthenes | 2009 |
Identification of Akt-selective cytotoxic compounds that enhance cytotoxic responses to rapamycin.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Caspase 3; Cell Line; Cell Membrane; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; High-Throughput Screening Assays; Mice; Oxazines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirolimus; Xanthenes | 2010 |
Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
Topics: Amino Acids; Analysis of Variance; Animals; Bridged Bicyclo Compounds; Depression; Dicarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Hindlimb Suspension; Ketamine; Male; Mice; Mice, Inbred ICR; Receptors, Metabotropic Glutamate; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Xanthenes | 2011 |
Enhancement of long-term depression by soluble amyloid β protein in rat hippocampus is mediated by metabotropic glutamate receptor and involves activation of p38MAPK, STEP and caspase-3.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Amyloid beta-Peptides; Animals; Caspase 3; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Hippocampus; Immunosuppressive Agents; In Vitro Techniques; Long-Term Synaptic Depression; Male; Methoxyhydroxyphenylglycol; p38 Mitogen-Activated Protein Kinases; Patch-Clamp Techniques; Peptide Fragments; Protein Tyrosine Phosphatases, Non-Receptor; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Sirolimus; Xanthenes | 2013 |
Triggering of Eryptosis, the Suicidal Erythrocyte Death by Mammalian Target of Rapamycin (mTOR) inhibitor Temsirolimus.
Topics: Aniline Compounds; Annexin A5; Antineoplastic Agents; Benzamides; Benzophenanthridines; Calcium; Casein Kinase I; Caspases; Ceramides; Eryptosis; Erythrocytes; Fluoresceins; Gene Expression Regulation; Hemolysis; Humans; Imidazoles; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Phosphatidylserines; Primary Cell Culture; Protein Kinase Inhibitors; Pyridines; Reactive Oxygen Species; Signal Transduction; Sirolimus; Staurosporine; TOR Serine-Threonine Kinases; Xanthenes | 2017 |